Allegra-d Allergy And Congestion Tablet, Film Coated, Extended Release
FDA Label NDC 41167-4320

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Chattem, Inc. for the product Allegra-d Allergy And Congestion (NDC 41167-4320). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, uses, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

(in each extended-release tablet)

Fexofenadine HCl 180 mg

(in each extended-release tablet) 

Pseudoephedrine HCl 240 mg

Purpose

Antihistamine

Nasal decongestant

Uses

  • temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
    ▪ runny nose
    ▪ sneezing
    ▪ itchy, watery eyes
    ▪ itching of the nose or throat
  • temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies
  • reduces swelling of nasal passages
  • temporarily relieves sinus congestion and pressure
  • temporarily restores freer breathing through the nose

Do Not Use

  • if you have ever had an allergic reaction to this product or any of its ingredients
  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI)
    (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
  • If you have difficulty swallowing

Ask A Doctor Before Use If You Have

  • heart disease
  • thyroid disease
  • glaucoma
  • high blood pressure
  • diabetes
  • trouble urinating due to an enlarged prostate gland
  • kidney disease. Your doctor should determine if you need a different dose.

When Using This Product

  • do not take more than directed
  • do not take at the same time as aluminum or magnesium antacids
  • do not take with fruit juices (see Directions)
  • the tablet coating may be seen in the stool (this is normal). Continue to take as directed (see Directions).

Stop Use And Ask A Doctor If

  • an allergic reaction to this product occurs. Seek medical help right away.
  • symptoms do not improve within 7 days or are accompanied by a fever
  • you get nervous, dizzy, or sleepless

If Pregnant Or Breast-Feeding,

ask a health professional before use.

Keep Out Of Reach Of Children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • do not divide, crush, chew or dissolve the tablet; swallow tablet whole
  • adults and children 12 years
    of age and over
    take 1 tablet with a glass of water
    every 24 hours on an empty stomach; do
    not take more than 1 tablet in 24 hours
    children under 12 years of agedo not use
    adults 65 years of age and olderask a doctor
    consumers with kidney diseaseask a doctor

Other Information

  • each tablet contains: sodium 33 mg
  • safety sealed: do not use if carton is opened or if individual blister units are torn or opened
  • store between 20° and 25°C (68° and 77°F)

Inactive Ingredients

acetone, black iron oxide, cellulose acetate, colloidal silicon dioxide, copovidone, croscarmellose sodium, FD&C blue #1 aluminum lake, glycerol triacetate, hypromellose, isopropyl alcohol, magnesium stearate, microcrystalline cellulose, polyethylene glycol, propylene glycol, povidone, sodium chloride, talc, titanium dioxide, water

Questions Or Comments?

call toll-free 1-800-633-1610 or www.allegra.com

Principal Display Panel

NDC 41167-4320-7
NON-DROWSY
Allegra-D®
ALLERGY & CONGESTION
fexofenadine HCl 180 mg/antihistamine
pseudoephedrine HCl 240 mg/nasal decongestant
Extended Release Tablets
15 Tablets

Principal Display Panelndc 41167-4320-7non-drowsyallegra-d®allergy & Congestionfexofenadine HCl 180 mg/antihistaminepseudoephedrine HCl 240 mg/nasal Decongestantextended Release Tablets15 Tablets (Allegra D Allergy And Congestion 24 Hr 01)

Principal Display Panelndc 41167-4320-7non-drowsyallegra-d®allergy & Congestionfexofenadine HCl 180 mg/antihistaminepseudoephedrine HCl 240 mg/nasal Decongestantextended Release Tablets15 Tablets (Allegra D Allergy And Congestion 24 Hr 01)

* Please review the disclaimer below.